Pat Wheelan

1.1k total citations
39 papers, 863 citations indexed

About

Pat Wheelan is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Pat Wheelan has authored 39 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Virology and 11 papers in Infectious Diseases. Recurrent topics in Pat Wheelan's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and Analytical Chemistry and Chromatography (7 papers). Pat Wheelan is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (11 papers) and Analytical Chemistry and Chromatography (7 papers). Pat Wheelan collaborates with scholars based in United States, Slovakia and France. Pat Wheelan's co-authors include Robert C. Murphy, Joseph A. Zirrolli, Andrew Spaltenstein, Michael M. Thomson, Kristjan S. Gudmundsson, Stephen Jenkinson, John F. Miller, Joseph A. Hankin, R.C. Murphy and Sharon Boggs and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Pat Wheelan

39 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pat Wheelan United States 17 402 272 134 119 113 39 863
Suresh Yeola United States 15 600 1.5× 305 1.1× 100 0.7× 66 0.6× 48 0.4× 24 1.1k
Norbert Dereu France 17 380 0.9× 439 1.6× 34 0.3× 73 0.6× 45 0.4× 37 1.0k
Alexander V. Veselovsky Russia 18 662 1.6× 154 0.6× 60 0.4× 63 0.5× 101 0.9× 90 1.1k
Martin P. Edwards United States 15 518 1.3× 492 1.8× 116 0.9× 42 0.4× 80 0.7× 30 1.2k
Sathesh Bhat United States 13 968 2.4× 157 0.6× 133 1.0× 91 0.8× 41 0.4× 21 1.5k
Khalid S. Ishaq United States 15 420 1.0× 160 0.6× 66 0.5× 130 1.1× 43 0.4× 34 686
Keith Biggadike United Kingdom 19 621 1.5× 605 2.2× 51 0.4× 52 0.4× 64 0.6× 45 1.4k
Аndrey G. Pokrovsky Russia 18 411 1.0× 292 1.1× 49 0.4× 25 0.2× 49 0.4× 78 835
David E. Zembower United States 16 645 1.6× 481 1.8× 147 1.1× 49 0.4× 24 0.2× 26 1.1k
Nigel G. Ramsden United Kingdom 19 942 2.3× 1.1k 4.0× 42 0.3× 70 0.6× 51 0.5× 25 1.5k

Countries citing papers authored by Pat Wheelan

Since Specialization
Citations

This map shows the geographic impact of Pat Wheelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Wheelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Wheelan more than expected).

Fields of papers citing papers by Pat Wheelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pat Wheelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Wheelan. The network helps show where Pat Wheelan may publish in the future.

Co-authorship network of co-authors of Pat Wheelan

This figure shows the co-authorship network connecting the top 25 collaborators of Pat Wheelan. A scholar is included among the top collaborators of Pat Wheelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pat Wheelan. Pat Wheelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duan, Maosheng, George A. Freeman, Robert G. Ferris, et al.. (2011). Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1. Bioorganic & Medicinal Chemistry Letters. 21(5). 1394–1398. 9 indexed citations
2.
Duan, Maosheng, Wieslaw M. Kazmierski, Pek Y. Chong, et al.. (2011). Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats. Bioorganic & Medicinal Chemistry Letters. 21(21). 6470–6475. 9 indexed citations
3.
Duan, Maosheng, Wieslaw M. Kazmierski, Mark Edelstein, et al.. (2011). Discovery of a novel series of cyclic urea as potent CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(21). 6381–6385. 9 indexed citations
4.
Catalano, John G., Kristjan S. Gudmundsson, Sharon Boggs, et al.. (2010). Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 20(7). 2186–2190. 34 indexed citations
5.
Duan, Maosheng, Mark Edelstein, Robert G. Ferris, et al.. (2010). Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (II): Modification of the acyl portion. Bioorganic & Medicinal Chemistry Letters. 20(24). 7401–7404. 6 indexed citations
6.
Miller, John F., Elizabeth M. Turner, Kristjan S. Gudmundsson, et al.. (2010). Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents. Bioorganic & Medicinal Chemistry Letters. 20(7). 2125–2128. 77 indexed citations
7.
Miller, John F., et al.. (2010). Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity. Bioorganic & Medicinal Chemistry Letters. 20(10). 3026–3030. 33 indexed citations
8.
Duan, Maosheng, Mark Edelstein, Robert G. Ferris, et al.. (2010). Discovery of N-benzyl-N′-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): Optimization of the amine portion. Bioorganic & Medicinal Chemistry Letters. 20(24). 7397–7400. 9 indexed citations
9.
Gudmundsson, Kristjan S., Sharon Boggs, John G. Catalano, et al.. (2009). Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 19(22). 6399–6403. 74 indexed citations
10.
Jenkinson, Stephen, Michael M. Thomson, David McCoy, et al.. (2009). Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist. Antimicrobial Agents and Chemotherapy. 54(2). 817–824. 55 indexed citations
11.
Duan, Maosheng, Christopher Aquino, Robert G. Ferris, et al.. (2009). [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring. Bioorganic & Medicinal Chemistry Letters. 19(6). 1610–1613. 16 indexed citations
12.
Yao, Xiaozhou, D. L. Anderson, Sean Ross, et al.. (2008). Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea‐pig model. British Journal of Pharmacology. 154(7). 1446–1456. 56 indexed citations
13.
Sherrill, Ronald G., Eric S. Furfine, Richard Hazen, et al.. (2005). Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(15). 3560–3564. 8 indexed citations
14.
Hankin, Joseph A., Pat Wheelan, & Robert C. Murphy. (1997). Identification of Novel Metabolites of Prostaglandin E2Formed by Isolated Rat Hepatocytes. Archives of Biochemistry and Biophysics. 340(2). 317–330. 28 indexed citations
15.
16.
Wheelan, Pat, Robert C. Murphy, & Francis R. Simon. (1996). Gas Chromatographic/Mass Spectrometric Analysis of Oxo and Chain-shortened Leukotriene B4 Metabolites. Leukotriene B4 Metabolism in Ito Cells. Journal of Mass Spectrometry. 31(3). 236–246. 5 indexed citations
17.
Wheelan, Pat & Robert C. Murphy. (1995). Metabolism of Leukotriene B4 in Cultured Hepatoma Cells. Archives of Biochemistry and Biophysics. 321(2). 381–389. 8 indexed citations
18.
Wheelan, Pat & Robert C. Murphy. (1995). Metabolism of 6-trans-Isomers of Leukotriene B4 in Cultured Hepatoma Cells and in Human Polymorphonuclear Leukocytes. Journal of Biological Chemistry. 270(34). 19845–19852. 11 indexed citations
19.
Wheelan, Pat, Jeffrey B. Travers, Joseph G. Morelli, & Robert C. Murphy. (1994). Metabolism of Leukotriene B4 (LTB4) and 12‐Hydroxy‐5,8,10,14‐Eicosatetraenoic Acid (12‐HETE) in Human Keratinocytesa. Annals of the New York Academy of Sciences. 744(1). 39–49. 1 indexed citations
20.
Wheelan, Pat, Joseph A. Zirrolli, & Robert C. Murphy. (1993). Low-energy fast atom bombardment tandem mass spectrometry of monohydroxy substituted unsaturated fatty acids. Journal of Mass Spectrometry. 22(8). 465–473. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suresh Yeola Breakdown of academic impact, for papers by Norbert Dereu Breakdown of academic impact, for papers by Alexander V. Veselovsky Breakdown of academic impact, for papers by Martin P. Edwards Breakdown of academic impact, for papers by Sathesh Bhat Breakdown of academic impact, for papers by Khalid S. Ishaq Breakdown of academic impact, for papers by Keith Biggadike Breakdown of academic impact, for papers by Аndrey G. Pokrovsky Breakdown of academic impact, for papers by David E. Zembower Breakdown of academic impact, for papers by Nigel G. Ramsden
Rankless by CCL
2026